|
摘要：
|
|
摘要：肝硬化是不同慢性肝脏疾病的共同发展阶段，表现为正常的肝实质被纤维化组
织和再生结节取代，临床发病率和病死率高。肝硬化严重影响人群健康水平，但目前
尚缺乏有效的治疗药物。中医药治疗代偿期肝硬化历史悠久、理论方药丰富，疗效得
到广大医生和患者的认可。为进一步提高代偿期肝硬化的中医药疗效，深圳市中医院
肝病科依托国家中医药管理局华南区中医肝病诊疗中心，牵头联合联盟单位肝病专
家，以国家中医药管理局发布的《积聚（肝硬化）诊疗方案》为蓝本，结合肝硬化的
研究进展，更新、修订形成了《积聚（肝硬化代偿期）中医诊疗方案》，为华东南积
聚（肝硬化代偿期）的中医预防、辨证治疗提供依据。
|
|
Abstract: Liver cirrhosis is a co-developmental stage of different chronic liver diseases,
representing the replacement of normal liver parenchyma with fibrotic tissue and regenerating
nodules, with high morbidity and mortality. Liver cirrhosis affects people’s health seriously
and there is still a lack of effective drug treatment. Traditional Chinese medicine (TCM) has
long history and abundant theoretical prescriptions in the treatment of compensatory stage of
cirrhosis, and its curative effect has been recognized by the majority of doctors and patients.
In order to furtherly improve the compensatory cirrhosis period of curative effect of TCM,
relying on the National Administration of Traditional Chinese Medicine South China Alliance
of TCM Hepatology Diagnosis and Treatment Center, the hepatology department of Shenzhen
Traditional Chinese Medicine Hospital cooperated with the experts in the joint coalition
units and formed TCM diagnosis and treatment scheme of Jiju (compensatory stage of liver
cirrhosis), which is based on the diagnosis and treatment scheme of Jiju (liver cirrhosis) issued
by the National Administration of Traditional Chinese Medicine. The aim of this new “TCM
diagnosis and treatment scheme of Jiju (compensatory stage of liver cirrhosis)” is to provide
basis for diagnosis and treatment of TCM on Jiju in Southeast China.
|
|
基金项目：
|
|
|
|
作者简介：
|
|
|
|
参考文献：
|
|
|
|
服务与反馈：
|
|
【文章下载】【加入收藏】
|
|
|
|